{"result": "(\"entity\"<|>REFETOFF S<|>PERSON<|>Refetoff S is a researcher involved in the study of inherited defects of thyroid hormone action and metabolism.)\n##\n(\"entity\"<|>BASSETT JH<|>PERSON<|>Bassett JH is a researcher who contributed to the classification and nomenclature for thyroid hormone action defects.)\n##\n(\"entity\"<|>BECK-PECCOZ P<|>PERSON<|>Beck-Peccoz P is a researcher who has published guidelines for the diagnosis and treatment of TSH-secreting pituitary tumors.)\n##\n(\"entity\"<|>BERNAL J<|>PERSON<|>Bernal J is a researcher who has contributed to the understanding of thyroid hormone action and metabolism.)\n##\n(\"entity\"<|>BRENT G<|>PERSON<|>Brent G is a researcher involved in the study of thyroid hormone action and its disorders.)\n##\n(\"entity\"<|>CHATTERJEE K<|>PERSON<|>Chatterjee K is a researcher who has worked on thyroid hormone action and its related disorders.)\n##\n(\"entity\"<|>THYROID HORMONE RESISTANCE<|>EVENT<|>Thyroid hormone resistance is a condition where tissues do not respond to thyroid hormones, leading to various clinical implications.)\n##\n(\"entity\"<|>TSHOMA<|>EVENT<|>TSHoma refers to tumors that produce thyroid-stimulating hormone, affecting thyroid hormone levels in the body.)\n##\n(\"entity\"<|>SHBG<|>ORGANIZATION<|>Sex hormone-binding globulin (SHBG) is a protein that binds to sex hormones and is used in clinical assessments of thyroid hormone resistance.)\n##\n(\"entity\"<|>EUROPEAN THYROID ASSOCIATION<|>ORGANIZATION<|>The European Thyroid Association provides guidelines for the diagnosis and treatment of thyroid-related disorders.)\n##\n(\"relationship\"<|>REFETOFF S<|>BECK-PECCOZ P<|>Refetoff S and Beck-Peccoz P are both researchers involved in thyroid hormone action studies and have published related works<|>7)\n##\n(\"relationship\"<|>BASSETT JH<|>BECK-PECCOZ P<|>Bassett JH and Beck-Peccoz P collaborated on the classification and proposed nomenclature for inherited defects of thyroid hormone action<|>8)\n##\n(\"relationship\"<|>BECK-PECCOZ P<|>EUROPEAN THYROID ASSOCIATION<|>Beck-Peccoz P is associated with the European Thyroid Association, which published guidelines for TSH-secreting tumors<|>9)\n##\n(\"relationship\"<|>CHATTERJEE K<|>BECK-PECCOZ P<|>Chatterjee K and Beck-Peccoz P have both contributed to the research on thyroid hormone action and its disorders<|>6)\n##\n(\"relationship\"<|>THYROID HORMONE RESISTANCE<|>TSHOMA<|>Thyroid hormone resistance and TSHoma are both conditions related to thyroid hormone action and regulation<|>5)\n##\n(\"relationship\"<|>SHBG<|>THYROID HORMONE RESISTANCE<|>SHBG levels are used to assess thyroid hormone resistance, indicating a relationship between the two<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet. 2004;74:168-75.\n- Refetoff S, Bassett JH, Beck-Peccoz P, Bernal J, Brent G, Chatterjee K, et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid. 2014;24:407-9.\n- Singh BK, Yen PM. A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms. Clin Diabetes Endocrinol. 2017;3:8.\n---\n# TIROIDES\n\n## 23. En relación con el diagnóstico diferencial entre los tumores hipofisarios productores de TSH y la resistencia a las hormonas tiroideas (RHT), señale la afirmación falsa:\n\nA. La respuesta de la TSH a la estimulación con TRH suele estar ausente en los tumores productores de TSH hipofisarios.\nB. La concentración de SHBG (globulina fijadora de hormonas sexuales) suele ser normal o baja en la RHT.\nC. La presencia de un microadenoma hipofisario en la prueba de imagen excluye completamente RHT.\nD. La elevación de la subunidad α es típica de los tumores.\n\n### COMENTARIO\n\nLos tumores hipofisarios productores de TSH tienen un perfil bioquímico similar a los síndromes de resistencia a hormonas tiroideas al presentar una T4 elevada con TSH igualmente elevada o inadecuadamente normal. Una de las pruebas para diferenciar ambas entidades es realizar una estimulación con TRH (200 µg i.v. en bolo). En los cuadros de resistencia a hormonas tiroideas, la TSH responde al estímulo con TRH, mientras que en los TSHomas no lo hacen en cerca de un 90% de los casos. Así, en una revisión de 43 tumores hipofisarios productores de TSH, no hubo respuesta a la administración de TRH en 31 de 38 (81%) de los pacientes en los que se realizó. Por consiguiente, la afirmación A es verdadera.\n\nOtra de las pruebas analíticas que se utilizan para diferenciar ambos cuadros es la determinación de la SHBG (globulina fijadora de hormonas sexuales). Esta proteína se encuentra elevada como reflejo de la acción del exceso de hormonas tiroideas a nivel del tejido hepático, como sucede en el hipertiroidismo por TSHomas. En cambio, en la resistencia a hormonas tiroideas, los tejidos periféricos no responden al estímulo de las hormonas tiroideas y los niveles de SHBG son más bajos. Así, Beck-Peccoz et al. publicaron que en 7 pacientes con resistencia a hormonas tiroideas los niveles de SHBG eran de 40,5 ± 11,8 (±DE) nmol/l (rango, 26,4-57,5) mientras que en los 17 pacientes con TSHomas eran significativamente mayores: 99,5 ± 54,7 nmol/l (rango, 21,6-259). Por lo tanto, la opción B también es verdadera.\n\nLógicamente, la presencia de un tumor hipofisario apoya fuertemente la posibilidad de un TSHoma frente a una resistencia a hormonas tiroideas. Sin embargo, hay que tener en cuenta que los TSHomas son macroadenomas en un 80% de los casos y que el hallazgo incidental de microadenomas hipofisarios no funcionantes es un hallazgo que aparece en un 10% de las RMN practicadas a individuos normales, por lo que la presencia de un microadenoma hipofisario no asegura que sea el responsable de una elevación de la TSH, pudiendo tratarse de una asociación casual. Así, se han descrito casos de la coincidencia de ambas patologías (opción C falsa).\n\nFinalmente, los niveles de la subunidad α se encuentran elevados en alrededor de un 70% de los pacientes con tumores hipofisarios productores de TSH, particularmente en aquellos con macroadenomas hipofisarios, lo que ayuda en su diferenciación de los cuadros de resistencia a hormonas tiroideas (opción D verdadera).\n\nReferencias:\n- Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau J.-L. 2013 European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors. Eur Thyroid J. 2013;2:76-82.\n- Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, et al. G Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab. 1990;71:19-25.\n- Lucas T, Páramo C\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}